查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1547598

全球无创产前检测市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

Global Noninvasive Prenatal Testing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 233 Pages | 商品交期: 最快1-2个工作天内

价格

全球非侵入性产前检测市场需求预计将从 2023 年的 47.1 亿美元达到近 49.6 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 0.58%。

非侵入性产前检测 (NIPT) 是一种筛检方法，用于识别发育中胎儿的遗传异常，无需采取羊膜穿刺术或绒毛膜绒毛取样等侵入性操作。 NIPT 分析母亲血液中循环的胎儿游离DNA，以评估染色体疾病的风险，包括爱德华兹症候群（18 三体）、唐氏症（21 三体症）和帕陶氏症候群（13 三体症）以及特定的性染色体异常。与传统的产前检测方法相比，NIPT 提供了更安全、更准确的选择，通常可以在怀孕早期获得结果。

市场动态

推动非侵入性产前检测市场的因素包括对早期准确检测胎儿异常的需求不断增长、非侵入性产前筛检测试的日益普及以及基因检测技术的进步。随着孕产妇年龄的增加和对产前筛检选择的认识不断提高，对非侵入性产前检测的需求不断增长。此外，定序技术、生物资讯学和遗传分析方法的技术进步推动了 NIPT 的创新，提高了检测胎儿遗传异常的准确性、敏感度和特异性。此外，NIPT 筛检的遗传性疾病范围不断扩大，包括微缺失和性染色体非整倍体，透过解决未满足的临床需求和改善患者护理，进一步刺激市场成长。此外，专业医学会和监管机构对 NIPT 的认可以及医疗保健支付者的报销范围提高了孕妇对 NIPT 的可及性和采用率。然而，监管障碍和报销挑战可能会阻碍未来几年无创产前检测市场的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球无创产前检测市场的各个细分市场进行了包容性评估。非侵入性产前检测产业的成长和趋势为这项研究提供了整体方法。

市场区隔

非侵入性产前检测市场报告的这一部分提供了有关国家和区域级别细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按妊娠期

  • 0-12週
  • 13-24週
  • 25-36週

按怀孕风险

  • 高风险和中等风险
  • 低风险

依方法

  • 超音波检测
  • 生化筛选试验
  • 母体血浆检测中的游离 DNA

依技术

  • NGS
  • 阵列技术
  • 聚合酶炼式反应
  • 其他的

按产品分类

  • 耗材及试剂
  • 仪器仪表

按申请

  • 三体性
  • 微缺失症候群
  • 其他应用

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲无创产前检测市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。非侵入性产前检测市场的主要参与者包括 Genesis Genetics (CooperSurgical Inc.)、Natera Inc.、Centogene NV、Illumina Inc. (Verinata Health Inc.)、Eurofins LifeCodexx GmbH、MedGenome Labs Ltd.、F. Hoffmann-La Roche Ltd.、(Ariosa Diagnostics)、Myriad Women'S Health Inc. (Counsyl Inc.)、QIAGEN、Laboratory Corp. Of America Holdings、Progenity Inc.、Quest Diagnostics Inc. 本部分包含竞争格局的整体视图，其中包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：非侵入性产前检测 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按酝酿期间的市场吸引力分析
    • 以怀孕风险进行的市场吸引力分析
    • 市场吸引力分析方法
    • 按技术分類的市场吸引力分析
    • 按产品分類的市场吸引力分析
    • 市场吸引力分析：依应用分类
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球非侵入性产前检测市场分析：依妊娠期分类

  • 按妊娠期概述
  • 历史和预测数据
  • 按妊娠分析
  • 0-12週
  • 13-24週
  • 25-36週

第 6 章：全球非侵入性产前检测市场分析：依怀孕风险分类

  • 按怀孕风险概述
  • 历史和预测数据
  • 按怀孕风险分析
  • 高风险和中等风险
  • 低风险

第 7 章：全球非侵入性产前检测市场分析：依方法

  • 依方法概述
  • 历史和预测数据
  • 方法分析
  • 超音波检测
  • 生化筛选试验
  • 母体血浆检测中的游离 DNA

第 8 章：全球非侵入性产前检测市场分析：依技术分类

  • 依技术概述
  • 历史和预测数据
  • 技术分析
  • NGS
  • 阵列技术
  • 聚合酶炼式反应
  • 其他的

第 9 章：全球无创产前检测市场分析：按产品

  • 概述（按产品）
  • 历史和预测数据
  • 按产品分析
  • 耗材及试剂
  • 仪器仪表

第 10 章：全球非侵入性产前检测市场分析：按应用分类

  • 概述：按应用
  • 历史和预测数据
  • 分析：按应用
  • 三体性
  • 微缺失症候群
  • 其他应用

第 11 章：全球无创产前检测市场分析：按地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 12 章：非侵入性产前检测公司的竞争格局

  • 非侵入性产前检测市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 13 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Genesis Genetics (CooperSurgical Inc.)
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Natera Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Centogene NV
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Illumina Inc. (Verinata Health Inc.)
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Eurofins LifeCodexx GmbH
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • MedGenome Labs Ltd.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • F. Hoffmann-La Roche Ltd.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • (Ariosa Diagnostics)
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Myriad Women'S Health Inc. (Counsyl Inc.)
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • QIAGEN
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Laboratory Corp. Of America Holdings
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Progenity Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Quest Diagnostics Inc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

Product Code: VMR11214554

The global demand for Noninvasive Prenatal Testing Market is presumed to reach the market size of nearly USD 4.96 Billion by 2032 from USD 4.71 Billion in 2023 with a CAGR of 0.58% under the study period 2024-2032.

Noninvasive prenatal testing (NIPT) is a screening method used to identify genetic anomalies in a developing fetus without resorting to invasive procedures like amniocentesis or chorionic villus sampling. NIPT analyzes cell-free fetal DNA circulating in the mother's bloodstream to assess the risk of chromosomal disorders, including Edwards syndrome (trisomy 18), Down syndrome (trisomy 21), and Patau syndrome (trisomy 13), as well as specific sex chromosome abnormalities. NIPT offers a safer and more accurate option compared to traditional prenatal testing methods, with results typically available early in pregnancy.

MARKET DYNAMICS

The factors driving the noninvasive prenatal testing market include the spurring demand for early & accurate detection of fetal abnormalities, the growing adoption of noninvasive prenatal screening tests, and advancements in genetic testing technologies. With the rising maternal age and the increasing awareness of prenatal screening options, there is a growing demand for noninvasive prenatal testing. Additionally, technological advancements in sequencing technologies, bioinformatics, and genetic analysis methods drive innovation in NIPT, offering improved accuracy, sensitivity, and specificity in detecting fetal genetic abnormalities. Moreover, the expanding range of genetic conditions screened by NIPT, including microdeletions and sex chromosome aneuploidies, further stimulates market growth by addressing unmet clinical needs and improving patient care. Furthermore, the endorsement of NIPT by professional medical societies and regulatory agencies and reimbursement coverage by healthcare payers enhances accessibility and adoption of NIPT among pregnant women. However, regulatory hurdles and reimbursement challenges may hinder the growth of the noninvasive prenatal testing market in the next few years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Noninvasive Prenatal Testing. The growth and trends of Noninvasive Prenatal Testing industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Noninvasive Prenatal Testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Gestation Period

  • 0-12 Weeks
  • 13-24 Weeks
  • 25-36 Weeks

By Pregnancy Risk

  • High & Average Risk
  • Low Risk

By Method

  • Ultrasound Detection
  • Biochemical Screening Tests
  • Cell-free DNA in Maternal Plasma Tests

By Technology

  • NGS
  • Array Technology
  • PCR
  • Others

By Product

  • Consumables & Reagents
  • Instruments

By Application

  • Trisomy
  • Microdeletion Syndrome
  • Other Applications

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Noninvasive Prenatal Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Noninvasive Prenatal Testing market include Genesis Genetics (CooperSurgical Inc.), Natera Inc., Centogene N.V., Illumina Inc. (Verinata Health Inc.), Eurofins LifeCodexx GmbH, MedGenome Labs Ltd., F. Hoffmann-La Roche Ltd., (Ariosa Diagnostics), Myriad Women'S Health Inc. (Counsyl Inc.), QIAGEN, Laboratory Corp. Of America Holdings, Progenity Inc., Quest Diagnostics Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. NONINVASIVE PRENATAL TESTING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Gestation Period
    • 3.7.2 Market Attractiveness Analysis By Pregnancy Risk
    • 3.7.3 Market Attractiveness Analysis By Method
    • 3.7.4 Market Attractiveness Analysis By Technology
    • 3.7.5 Market Attractiveness Analysis By Product
    • 3.7.6 Market Attractiveness Analysis By Application
    • 3.7.7 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL NONINVASIVE PRENATAL TESTING MARKET ANALYSIS BY GESTATION PERIOD

  • 5.1. Overview By Gestation Period
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Gestation Period
  • 5.4. 0-12 Weeks Historic and Forecast Sales By Regions
  • 5.5. 13-24 Weeks Historic and Forecast Sales By Regions
  • 5.6. 25-36 Weeks Historic and Forecast Sales By Regions

6. GLOBAL NONINVASIVE PRENATAL TESTING MARKET ANALYSIS BY PREGNANCY RISK

  • 6.1. Overview By Pregnancy Risk
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Pregnancy Risk
  • 6.4. High & Average Risk Historic and Forecast Sales By Regions
  • 6.5. Low Risk Historic and Forecast Sales By Regions

7. GLOBAL NONINVASIVE PRENATAL TESTING MARKET ANALYSIS BY METHOD

  • 7.1. Overview By Method
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By Method
  • 7.4. Ultrasound Detection Historic and Forecast Sales By Regions
  • 7.5. Biochemical Screening Tests Historic and Forecast Sales By Regions
  • 7.6. Cell-free DNA in Maternal Plasma Tests Historic and Forecast Sales By Regions

8. GLOBAL NONINVASIVE PRENATAL TESTING MARKET ANALYSIS BY TECHNOLOGY

  • 8.1. Overview By Technology
  • 8.2. Historical and Forecast Data
  • 8.3. Analysis By Technology
  • 8.4. NGS Historic and Forecast Sales By Regions
  • 8.5. Array Technology Historic and Forecast Sales By Regions
  • 8.6. PCR Historic and Forecast Sales By Regions
  • 8.7. Others Historic and Forecast Sales By Regions

9. GLOBAL NONINVASIVE PRENATAL TESTING MARKET ANALYSIS BY PRODUCT

  • 9.1. Overview By Product
  • 9.2. Historical and Forecast Data
  • 9.3. Analysis By Product
  • 9.4. Consumables & Reagents Historic and Forecast Sales By Regions
  • 9.5. Instruments Historic and Forecast Sales By Regions

10. GLOBAL NONINVASIVE PRENATAL TESTING MARKET ANALYSIS BY APPLICATION

  • 10.1. Overview By Application
  • 10.2. Historical and Forecast Data
  • 10.3. Analysis By Application
  • 10.4. Trisomy Historic and Forecast Sales By Regions
  • 10.5. Microdeletion Syndrome Historic and Forecast Sales By Regions
  • 10.6. Other Applications Historic and Forecast Sales By Regions

11. GLOBAL NONINVASIVE PRENATAL TESTING MARKET ANALYSIS BY GEOGRAPHY

  • 11.1. Regional Outlook
  • 11.2. Introduction
  • 11.3. North America Sales Analysis
    • 11.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 11.3.2 North America By Segment Sales Analysis
    • 11.3.3 North America By Country Sales Analysis
    • 11.3.4 United States Sales Analysis
    • 11.3.5 Canada Sales Analysis
    • 11.3.6 Mexico Sales Analysis
  • 11.4. Europe Sales Analysis
    • 11.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 11.4.2 Europe By Segment Sales Analysis
    • 11.4.3 Europe By Country Sales Analysis
    • 11.4.4 United Kingdom Sales Analysis
    • 11.4.5 France Sales Analysis
    • 11.4.6 Germany Sales Analysis
    • 11.4.7 Italy Sales Analysis
    • 11.4.8 Russia Sales Analysis
    • 11.4.9 Rest Of Europe Sales Analysis
  • 11.5. Asia Pacific Sales Analysis
    • 11.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 11.5.2 Asia Pacific By Segment Sales Analysis
    • 11.5.3 Asia Pacific By Country Sales Analysis
    • 11.5.4 China Sales Analysis
    • 11.5.5 India Sales Analysis
    • 11.5.6 Japan Sales Analysis
    • 11.5.7 South Korea Sales Analysis
    • 11.5.8 Australia Sales Analysis
    • 11.5.9 South East Asia Sales Analysis
    • 11.5.10 Rest Of Asia Pacific Sales Analysis
  • 11.6. Latin America Sales Analysis
    • 11.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 11.6.2 Latin America By Segment Sales Analysis
    • 11.6.3 Latin America By Country Sales Analysis
    • 11.6.4 Brazil Sales Analysis
    • 11.6.5 Argentina Sales Analysis
    • 11.6.6 Peru Sales Analysis
    • 11.6.7 Chile Sales Analysis
    • 11.6.8 Rest of Latin America Sales Analysis
  • 11.7. Middle East & Africa Sales Analysis
    • 11.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 11.7.2 Middle East & Africa By Segment Sales Analysis
    • 11.7.3 Middle East & Africa By Country Sales Analysis
    • 11.7.4 Saudi Arabia Sales Analysis
    • 11.7.5 UAE Sales Analysis
    • 11.7.6 Israel Sales Analysis
    • 11.7.7 South Africa Sales Analysis
    • 11.7.8 Rest Of Middle East And Africa Sales Analysis

12. COMPETITIVE LANDSCAPE OF THE NONINVASIVE PRENATAL TESTING COMPANIES

  • 12.1. Noninvasive Prenatal Testing Market Competition
  • 12.2. Partnership/Collaboration/Agreement
  • 12.3. Merger And Acquisitions
  • 12.4. New Product Launch
  • 12.5. Other Developments

13. COMPANY PROFILES OF NONINVASIVE PRENATAL TESTING INDUSTRY

  • 13.1. Top Companies Market Share Analysis
  • 13.2. Market Concentration Rate
  • 13.3. Genesis Genetics (CooperSurgical Inc.)
    • 13.3.1 Company Overview
    • 13.3.2 Company Revenue
    • 13.3.3 Products
    • 13.3.4 Recent Developments
  • 13.4. Natera Inc.
    • 13.4.1 Company Overview
    • 13.4.2 Company Revenue
    • 13.4.3 Products
    • 13.4.4 Recent Developments
  • 13.5. Centogene N.V.
    • 13.5.1 Company Overview
    • 13.5.2 Company Revenue
    • 13.5.3 Products
    • 13.5.4 Recent Developments
  • 13.6. Illumina Inc. (Verinata Health Inc.)
    • 13.6.1 Company Overview
    • 13.6.2 Company Revenue
    • 13.6.3 Products
    • 13.6.4 Recent Developments
  • 13.7. Eurofins LifeCodexx GmbH
    • 13.7.1 Company Overview
    • 13.7.2 Company Revenue
    • 13.7.3 Products
    • 13.7.4 Recent Developments
  • 13.8. MedGenome Labs Ltd.
    • 13.8.1 Company Overview
    • 13.8.2 Company Revenue
    • 13.8.3 Products
    • 13.8.4 Recent Developments
  • 13.9. F. Hoffmann-La Roche Ltd.
    • 13.9.1 Company Overview
    • 13.9.2 Company Revenue
    • 13.9.3 Products
    • 13.9.4 Recent Developments
  • 13.10. (Ariosa Diagnostics)
    • 13.10.1 Company Overview
    • 13.10.2 Company Revenue
    • 13.10.3 Products
    • 13.10.4 Recent Developments
  • 13.11. Myriad Women'S Health Inc. (Counsyl Inc.)
    • 13.11.1 Company Overview
    • 13.11.2 Company Revenue
    • 13.11.3 Products
    • 13.11.4 Recent Developments
  • 13.12. QIAGEN
    • 13.12.1 Company Overview
    • 13.12.2 Company Revenue
    • 13.12.3 Products
    • 13.12.4 Recent Developments
  • 13.13. Laboratory Corp. Of America Holdings
    • 13.13.1 Company Overview
    • 13.13.2 Company Revenue
    • 13.13.3 Products
    • 13.13.4 Recent Developments
  • 13.14. Progenity Inc.
    • 13.14.1 Company Overview
    • 13.14.2 Company Revenue
    • 13.14.3 Products
    • 13.14.4 Recent Developments
  • 13.15. Quest Diagnostics Inc
    • 13.15.1 Company Overview
    • 13.15.2 Company Revenue
    • 13.15.3 Products
    • 13.15.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Gestation Period (USD MN)
  • 0-12 Weeks Market Sales By Geography (USD MN)
  • 13-24 Weeks Market Sales By Geography (USD MN)
  • 25-36 Weeks Market Sales By Geography (USD MN)
  • Analysis By Pregnancy Risk (USD MN)
  • High & Average Risk Market Sales By Geography (USD MN)
  • Low Risk Market Sales By Geography (USD MN)
  • Analysis By Method (USD MN)
  • Ultrasound Detection Market Sales By Geography (USD MN)
  • Biochemical Screening Tests Market Sales By Geography (USD MN)
  • Cell-free DNA in Maternal Plasma Tests Market Sales By Geography (USD MN)
  • Analysis By Technology (USD MN)
  • NGS Market Sales By Geography (USD MN)
  • Array Technology Market Sales By Geography (USD MN)
  • PCR Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Product (USD MN)
  • Consumables & Reagents Market Sales By Geography (USD MN)
  • Instruments Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Trisomy Market Sales By Geography (USD MN)
  • Microdeletion Syndrome Market Sales By Geography (USD MN)
  • Other Applications Market Sales By Geography (USD MN)
  • Global Noninvasive Prenatal Testing Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Noninvasive Prenatal Testing Report
  • Market Research Process
  • Market Research Methodology
  • Global Noninvasive Prenatal Testing Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Gestation Period
  • Market Attractiveness Analysis By Pregnancy Risk
  • Market Attractiveness Analysis By Method
  • Market Attractiveness Analysis By Technology
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Gestation Period (USD MN)
  • 0-12 Weeks Market Sales By Geography (USD MN)
  • 13-24 Weeks Market Sales By Geography (USD MN)
  • 25-36 Weeks Market Sales By Geography (USD MN)
  • Global Market Analysis By Pregnancy Risk (USD MN)
  • High & Average Risk Market Sales By Geography (USD MN)
  • Low Risk Market Sales By Geography (USD MN)
  • Global Market Analysis By Method (USD MN)
  • Ultrasound Detection Market Sales By Geography (USD MN)
  • Biochemical Screening Tests Market Sales By Geography (USD MN)
  • Cell-free DNA in Maternal Plasma Tests Market Sales By Geography (USD MN)
  • Global Market Analysis By Technology (USD MN)
  • NGS Market Sales By Geography (USD MN)
  • Array Technology Market Sales By Geography (USD MN)
  • PCR Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Product (USD MN)
  • Consumables & Reagents Market Sales By Geography (USD MN)
  • Instruments Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Trisomy Market Sales By Geography (USD MN)
  • Microdeletion Syndrome Market Sales By Geography (USD MN)
  • Other Applications Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.